2016 - IPITA - Stem Cell Derived Beta Cells Workshop

This page contains exclusive content for the member of the following sections: TTS, IPITA. Log in to view.

Road to the clinic and pre-IND studies

13.2 - Stem cell therapy regulatory issues from an EU perspective

Presenter: Giovanni, Migliaccio, Amsterdam, Netherlands
Authors: Giovanni Migliaccio

In Europe, the use of cells for therapeutic purposes suffers from a split personality as three different set of rules are applied by different competent authorities. Overall the members of the European Union recognize that a form of harmonization is needed to favor exchanges across the borders of these products and the establishment of best common practices.
Blood and Blood product are covered by the Directive 2002-98-EC  and its application is demanded to the National Competent Authorities (NCA) through the implementation in national laws.
 Human Cell and Tissue collection and distribution for human use is regulated by the Directive 2004-23-EC and the technical parameters defining the minimal requisite for the Cell and Tissue Centers are defined in the Dir. 2006-17-EC and 2006-86-EC. Again their application is demanded to the NCAs through the implementation in national laws.
The legal framework for medicinal products differs substantially as the  authorization for marketing is centralized and demanded to the European Medicine Agency (EMA), while the manufacturing and development is owned by the NCA. Cell and Tissue as components of a medicinal product are covered by a specific law, the Regulation 1394/2007/EC.
The classification of cellular preparation according to the different rules and the guidelines on their development will be the argument of this presentation.

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.



Staff Directory


The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6